col0,col1,col2,col3,col4,col5
ponatinib,532.22,antineoplastic,Ret proto-oncogene,acute myeloid leukemia,medication
mifepristone,429.267,hormone antagonist,Nuclear receptor subfamily 1 group I member 2,ectopic pregnancy,chemical compound
ponatinib,532.22,antineoplastic,Ret proto-oncogene,acute myeloid leukemia,chemical compound
erlotinib,393.169,protein kinase inhibitor,Epidermal growth factor receptor,pancreatic cancer,alkyne
